EUVIMEDEUVIMED entdecken
Open Access

5-Fluorouracil as a targeted lacrimal gland therapy for chronic Stevens-Johnson syndrome: A pilot study

Swati Singh, Sayan Basu

Indian Journal of Ophthalmology · 2023

DOI: 10.4103/ijo.ijo_2647_22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Swati Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Ocular Regeneration (CORE); Brien Holden Center for Eye Research (BHERC), L V Prasad Eye Institute, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Lacrimal Apparatus, Stevens-Johnson Syndrome, Dry Eye Syndromes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The surgical technique of periglandular 5-fluorouracil (5-FU) injection and its effects on the morphology and function of the main lacrimal gland of patients with severe dry eye disease due to Stevens–Johnson syndrome (SJS) are reported.

Methods

5-FU, as a potential antifibrotic agent, is given in the dose of 0.1 ml (50 mg/ml), subconjunctivally into the periglandular fibrosed area of the palpebral lobe of the main lacrimal gland. The injection is given using 30G needle into the subconjunctival plane and not into the substance of palpebral lobe.

Results

Eight eyes (eight lobes) of seven chronic SJS patients (mean age, 32.5 years,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lacrimal ApparatusStevens-Johnson SyndromeDry Eye SyndromesHumansAdultPilot ProjectsTears

Stichwörter der Autor:innen

5-FluorouracilStevens–Johnson syndromelacrimal glandpalpebral lobetears

Autor:innen und Institutionen

  • Center for Ocular Regeneration (CORE); Brien Holden Center for Eye Research (BHERC), L V Prasad Eye Institute, Hyderabad, Telangana, India.
  • Brien Holden Center for Eye Research (BHERC); The Cornea Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Zitieren

APA

Singh, S., & Basu, S. (2023). 5-Fluorouracil as a targeted lacrimal gland therapy for chronic Stevens-Johnson syndrome: A pilot study. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2647_22

Vancouver

Singh S, Basu S. 5-Fluorouracil as a targeted lacrimal gland therapy for chronic Stevens-Johnson syndrome: A pilot study. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_2647_22

BibTeX
@article{Singh2023,
  author = {Singh, Swati and Basu, Sayan},
  title = {5-Fluorouracil as a targeted lacrimal gland therapy for chronic Stevens-Johnson syndrome: A pilot study},
  journal = {Indian Journal of Ophthalmology},
  year = {2023},
  doi = {10.4103/ijo.ijo_2647_22}
}
Kostenlos starten →